Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen's Spinraza Sales Plateau; The Challenge Is Keeping Up With The Successful Launch

Apr 24 2018

• By Jessica Merrill

Arrows miss target — Spinraza revenues missed analyst targets

Related Content

A Deal For Biogen, But Not The One Investors Are Waiting For

Jan 25 2018

Biogen's SMA Ambitions Run Up Against A New Deep-Pocketed Rival

Apr 09 2018

Biogen Re-Ups With Ionis In Search Of A Neuroscience 'Innovation Engine'

Apr 20 2018

Related Companies

Biogen, Inc.

Roche Holding AG

Novartis AG

AveXis, Inc.

Karyopharm Therapeutics

Bristol Myers Squibb Company

Remedy Pharmaceuticals Inc.

University of Pennsylvania

Ionis Pharmaceuticals, Inc.

Additional Topics

Sales & Earnings Business Strategies Commercial Neurology BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.